Pp'
s.
=
+=,:.,.,
ffn#
Editor
"'l'fj rj
*ii
i"i,]
tTil:'i
L
j.lij
fi
I'i
;j'i
iifl
ilrlI i;i:1r'1uf
i#Ri:i
irii* ir;
I
T-
i.:
{r
;.r
E
{
$
lti'1,,r
!
!-l'
;'l
1i
i;
-*ir
iiijii{nijt
".lf
T
g
t1&}
fii{
iii:irrl:
il,iiilniiii;i$
itliTi'l Ffr+F
ijiliii
i.r!1
ljiiit
t
"Tifiiiii
iiiii;.
i:tr
i!!
T
ii
!
lj
:"lT
il
ii
it
.Iij
T ;r
I
il
i: i;
i1
i{
il
; ii
As heart
diseases,
especiallY
coronaries, are the leading causes
of
death, research and
develoPment
(R&D) on
poteniially
useful
preparations
is
vital.
Even
in
the
early 90's,
R&D
were
initiated
by
this Association and
Aca-
demician Chen
Ke-ji
-
clinical applica-
tion
in
hospitals
in
Shanghai
and
Suzhou,
etc.
found
moderating effects
on
coronaries and angina
patients.
Sub-
sequent research
in
laboratory animals
found beneficial inhibition on platelet
aggregation; prevention of
blood
clots
in blood diversion collaterals; perfor-
mance of the capsule also exceeded
that
of concoctions.
The main
ingredi-
ent of
the
H303 capsule is
from
Red
Sage Root and chuanxiong; the former
promotes blood flow; decrease
blood
stasis and pathogenic heat; apart from
similar properties,
the
latter is also
a
pain killer and able to promote the flow
of "qi". By 1994, with collaboration with
the Beijing Toxicology & Pharmacology
Research
lnstitute,
pre-clinical toxicol-
ogy studies on
H303
capsules
were
completed.
By
early
1995,
the Associa-
tion worked on pre-clinical
application
with
the Pharmacological
Office of the
Beiiing Nuclear Medicine
Research
lnstitute. After an arduous journey
o{
over
10
years, the regulatory require-
ments of H303
for
clinical use
had
thus
been
obtained
at
a long
last.
The
Edi-
tor is
very
pleased
to
have the chance
of
interviewing these research workers,
Prof
Ding Lin Mao
and
Dr Han Ling.
FS#,1.8*
(Hs03)
ffif;"'
m?FHtEE
?'iililiiA)!i!
Ei,:;i,r't)i1)giiit)i?'i,\trz
l)-F
l{ifltT
l,;!,,ijt
zo.;['.if
'
l/l14l$,i;
*x^Ffr
EIs'
EAEft,= +
Z +
^
H€gfiel*
H!
E
tfq+&,F'
@'+fr
ftImE,L'ffifr)fi' flH+lEt'
F'ltlE)E
'ffitrxffiM-*=+'EmR
"
H+ftItr
it,L.ffiff)fi
,
ieEE,b,fi
,
HE*)fr+E'
tu=+h'..ffiE
"
trtL'
fiff#
A?
.
€-}T
'
ERHT,{F.A€AEHE,H4fiIE,bJEPE6H.WJ,
EHEtllF
i6,L.m
€,R
ffi
*fi
i#=afr
nH! E
RA
€Fl4
2
-
"
IE-
t€llft R+n
ilrift+-'
1ft
gft
ffi
.
*EF
.
€IE
, Wr9nfrn'
Fft^
rr
-
rrr.EEiil,ffi
'
+Fltt
'
i+E=+
€+
' 4fgjE)eEfi!trB6 '
ifEL*€HJT944H!,1.ttu
'
teZFxrh
"
+
lE
e0
+'ft
in'
6
;6'1R{ftEt#
CfE
l$F
trJ
H
Fi
+
+
l"lffi n?rt#.
ZR
HH
AYfr+fr,
D'
iE,\,
L.
f;i
)E
&
d{
=
fti
m
E,
L.
€
E
*i
\ts
H,
tr
tr-
E
r
)€
4
+nnfr
n
Ffi rn
D
#1i
a
fi
+rJ
i^ffi
.'
f,
tJ
E
t
Fa
tr'J'
fF
EA
+
+tp
fl
e.
t
ffr
Et
fl
ftt
*ffifr{X"Flilt,ffi
'
#fl#s'#,t flry=fr'fsffii7$lEliI
Lv+
nfrfr
'
F"
RtHE'
[ry#'fE]t)Eg!l "
H 7
E-
s)R^nfrn'
ifitt
ee4+!51-+
E
ft
Ef
€,m
fifi
n'
F"
*ffi,T.,+
S
;€'
L'
W#
FE
EERF
H!
+i' t'
fl
JLft^
m
"{R
;€
,1.EIIr,
Hg
E'fti$J
H!'fts
E
"
E
tL'
e5
+
ilJ
tr)6'1Rfieffi
C)XE
tE
+
E
F
FfiftEtH,fiftnfrn
'
if
+E*fiR+
#
-
+.EH!+R+tbg>F
'
*YtE
H#tT
7
Ffift
II
-
Itr^HE!,'1,ffi
",#)Ef
10
?+*itrtrF#F'
f<EA=FI
7
ffi+ll'ffi
*l
Ffi
E
W,
ffinfr
n
r
lF'
if fi
Jb
tr
tr
ffie.&fr!#*
-#
E
"
+
#
H
+AZ
4
ffiE+
BEf
fi!+A#e.fH€i* '
nEiEF€
J
Hir#-{thfrn#frE
EffiH!ffi'fn+
A-T
+
f€#lEf
r
++l?tH+'
f
r'{&iP5
-
ftEE)H
r
)e;EEfiS
H!
fEiEER
+JEfE
'
fr-i'-+1&lP1rkHEf;E5
lAHtnW.*E IEHEilr H!€gefrE{H
,L.'lE "
